A Role of myocardin related transcription factor-A (MRTF-A) in scleroderma related fibrosis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Shiwen, Xu ^a   Stratton, Richard ^a   Nikitorowicz Buniak, Joanna ^a   Ahmed Abdi, Bahja ^a   Ponticos, Markella ^a   Denton, Christopher ^a   Abraham, David ^a   Takahashi, Ayuko ^b   Suki, Bela ^b   Layne, Matthew D ^c   Lafyatis, Robert ^c   Smith, Barbara D ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Boston University   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CTGF PROTEIN, MOUSE; MKL1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CELL NUCLEUS; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KERATINOCYTE; MOUSE; MYOFIBROBLAST; NONHUMAN; SCLERODERMA; SKIN FIBROBLAST; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINEAGE; DRUG RESISTANCE; FIBROSIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS;

ANIMALS; CELL LINEAGE; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; DRUG RESISTANCE; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; MICE; MICE, KNOCKOUT; MYOFIBROBLASTS; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84940827835     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126015     Document Type: Article

References (90)

1. Gilbane AJ, Denton CP, Holmes AM. Scleroderma pathogenesis: A pivotal role for fibroblasts as effector cells. Arthritis Res Ther. 2013; 15(3):215. Epub 2013/06/26. doi:10.1186/ar4230PMID:23796020.
2. Wei J, Bhattacharyya S, Tourtellotte WG, Varga J. Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev. 2011; 10(5):267-75. Epub 2010/09/25. doi:10.1016/j.autrev.2010.09.015 PMID: 20863909.
3. Varga JA, Trojanowska M. Fibrosis in systemic sclerosis. Rheum Dis Clin North Am. 2008; 34(1):115- 43; vii. PMID: 18329536. doi:10.1016/j.rdc.2007.11.002.
4. Silver RM, Feghali-Bostwick CA. Editorial: molecular insights into systemic sclerosis-associated interstitial lung disease. Arthritis & rheumatology. 2014; 66(3):485-7doi:10.1002/art.38287 PMID: 24574206.
5. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum. 2000; 43(2):444-51. Epub 2000/02/29. doi:10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G PMID: 10693887.
6. Balbir-Gurman A, Denton CP, Nichols B, Knight CJ, Nahir AM, Martin G, et al. Non-invasive measurement of biomechanical skin properties in systemic sclerosis. Ann Rheum Dis. 2002; 61(3):237-41. Epub 2002/02/07. PMID: 11830429; PubMed Central PMCID: PMC1754026.
7. Sackson I, Wener M, Pollock PS, Dighe MK. Shear wave elastography: A novel quantitative approach for evaluating scleroderma skin. Arthritis and Rheumatism. 2013; 65(S10):abstract 2600.
8. Suki B, Ito S, Stamenovic D, Lutchen KR, Ingenito EP. Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces. J Appl Physiol. 2005; 98(5):1892-9. Epub 2005/04/15. doi:10.1152/japplphysiol.01087.2004 PMID: 15829722.
9. Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum. 2006; 54(11):3655-60. PMID: 17075814.
10. Perlish JS, Lemlich G, Fleischmajer R. Identification of collagen fibrils in scleroderma skin. J Invest Dermatol. 1988; 90(1):48-54. Epub 1988/01/01. PMID: 3335789.
11. Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Frontiers in pharmacology. 2014; 5:123. doi:10.3389/fphar.2014.00123 PMID: 24904424; PubMed Central PMCID: PMC4034148.
12. Zhao XH, Laschinger C, Arora P, Szaszi K, Kapus A, McCulloch CA. Force activates smooth muscle {alpha}-actin promoter activity through the Rho signaling pathway. J Cell Sci. 2007. PMID: 17456553.
13. Wang Z, Wang DZ, Pipes GC, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci U S A. 2003; 100(12):7129-34. PMID: 12756293.
14. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, et al. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A. 2002; 99 (23):14855-60. PMID: 12397177.
15. Asparuhova MB, Gelman L, Chiquet M. Role of the actin cytoskeleton in tuning cellular responses to external mechanical stress. Scand J Med Sci Sports. 2009; 19(4):490-9. doi:10.1111/j.1600-0838.2009.00928.x PMID: 19422655.
16. Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol. 2010; 11(5):353-65. PMID: 20414257. doi:10.1038/nrm2890.
17. Kuwahara K, Barrientos T, Pipes GC, Li S, Olson EN. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol. 2005; 25(8):3173-81. PMID: 15798203.
18. Du KL, Chen M, Li J, Lepore JJ, Mericko P, Parmacek MS. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J Biol Chem. 2004; 279(17):17578-86. doi:10.1074/jbc.M400961200 PMID: 14970199.
19. Luchsinger LL, Patenaude CA, Smith BD, Layne MD. Myocardin-related Transcription Factor-A Complexes Activate Type I Collagen Expression in Lung Fibroblasts. J Biol Chem. 2011; 286(51):44116-25 Epub 2011/11/04. doi:10.1074/jbc.M111.276931 PMID: 22049076; PubMed Central PMCID: PMC3243519.
20. Hayashi K, Watanabe B, Nakagawa Y, Minami S, Morita T. RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling. PLoS One. 2014; 9(2):e89016. Epub 2014/02/22. doi:10.1371/journal.pone.0089016 PMID: 24558465; PubMed Central PMCID: PMC3928398.
21. Minami T, Kuwahara K, Nakagawa Y, Takaoka M, Kinoshita H, Nakao K, et al. Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice. EMBO J. 2012. doi:10.1038/emboj.2012.296PMID: 23103763.
22. Evelyn CR, Bell JL, Ryu JG, Wade SM, Kocab A, Harzdorf NL, et al. Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423. Bioorganic & medicinal chemistry letters. 2010; 20(2):665-72. Epub 2009/12/08. doi:10.1016/j.bmcl.2009.11.056 PMID: 19963382; PubMed Central PMCID: PMC2818594.
23. Lafyatis R. Transforming growth factor beta-at the centre of systemic sclerosis. Nat Rev Rheumatol. 2014; 10(12):706-19. doi:10.1038/nrrheum.2014.137 PMID: 25136781.
24. Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol. 2004; 165(5):723-34. doi:10.1083/jcb. 200312172 PMID: 15184403; PubMed Central PMCID: PMC2172370.
25. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007; 179(6):1311-23. Epub 2007/12/19. doi:10.1083/jcb.200704042 PMID: 18086923; PubMed Central PMCID: PMC2140013.
26. Gupta M, Korol A, West-Mays JA. Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells. Mol Vis. 2013; 19:1017-28. Epub 2013/05/21. PMID: 23687438; PubMed Central PMCID: PMC3654857.
27. Crider BJ, Risinger GM Jr, Haaksma CJ, Howard EW, Tomasek JJ. Myocardin-related transcription factors A and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J Invest Dermatol. 2011; 131(12):2378-85. Epub 2011/07/22. doi:10.1038/jid.2011.219 PMID: 21776010; PubMed Central PMCID: PMC3199034.
28. Morita T, Mayanagi T, Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol. 2007; 179(5):1027-42. PMID: 18056415.
29. O'Connor JW, Riley PN, Nalluri SM, Ashar PK, Gomez EW. Matrix rigidity mediates TGFbeta1-induced epithelial-myofibroblast transition by controlling cytoskeletal organization and MRTF-A localization. J Cell Physiol. 2014. doi:10.1002/jcp.24895 PMID: 25522130.
30. Mihira H, Suzuki HI, Akatsu Y, Yoshimatsu Y, Igarashi T, Miyazono K, et al. TGF-beta-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. Journal of biochemistry. 2012; 151(2):145-56. Epub 2011/10/11. doi:10.1093/jb/mvr121 PMID: 21984612.
31. Talwar S, Jain N, Shivashankar GV. The regulation of gene expression during onset of differentiation by nuclear mechanical heterogeneity. Biomaterials. 2014; 35(8):2411-9. Epub 2014/01/07. doi:10.1016/j.biomaterials.2013.12.010 PMID: 24388387.
32. Gomez EW, Chen QK, Gjorevski N, Nelson CM. Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J Cell Biochem. 2010; 110(1):44-51. Epub 2010/03/26. doi:10.1002/jcb.22545PMID: 20336666; PubMed Central PMCID: PMC2858775.
33. Chan MW, Chaudary F, Lee W, Copeland JW, McCulloch CA. Force-induced Myofibroblast Differentiation through Collagen Receptors Is Dependent on Mammalian Diaphanous (mDia). J Biol Chem. 2010; 285(12):9273-81. PMID: 20071339. doi:10.1074/jbc.M109.075218.
34. Watt FM, Huck WT. Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol. 2013; 14(8):467-73. Epub 2013/07/11doi:10.1038/nrm3620 PMID: 23839578.
35. Tan KY, Lin H, Ramstedt M, Watt FM, Huck WT, Gautrot JE. Decoupling geometrical and chemical cues directing epidermal stem cell fate on polymer brush-based cell micro-patterns. Integrative biology: quantitative biosciences from nano to macro. 2013; 5(6):899-910. Epub 2013/04/11. doi:10.1039/c3ib40026cPMID: 23572192.
36. Trappmann B, Gautrot JE, Connelly JT, Strange DG, Li Y, Oyen ML, et al. Extracellular-matrix tethering regulates stem-cell fate. Nature materials. 2012; 11(7):642-9. Epub 2012/05/29. doi:10.1038/nmat3339 PMID: 22635042.
37. Huang X, Yang N, Fiore VF, Barker TH, Sun Y, Morris SW, et al. Matrix Stiffness-Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction. Am J Respir Cell Mol Biol. 2012. Epub 2012/03/31. doi:10.1165/rcmb.2012-0050OC PMID: 22461426.
38. Zhou Y, Huang X, Hecker L, Kurundkar D, Kurundkar A, Liu H, et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest. 2013. doi:10.1172/JCI66700PMID: 23434591.
39. Janmey PA, Wells RG, Assoian RK, McCulloch CA. From tissue mechanics to transcription factors. Differentiation. 2013; 86(3):112-20. Epub 2013/08/24doi:10.1016/j.diff.2013.07.004PMID: 23969122.
40. McGee KM, Vartiainen MK, Khaw PT, Treisman R, Bailly M. Nuclear transport of the serum response factor coactivator MRTF-A is downregulated at tensional homeostasis. EMBO Rep. 2011; 12(9):963- 70. Epub 2011/07/30. doi:10.1038/embor.2011.141 PMID: 21799516; PubMed Central PMCID: PMC3166461.
41. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res. 2010; 107(2):294-304. PMID: 20558820. doi:10.1161/CIRCRESAHA.110.223172.
42. Yuan Z, Chen J, Chen D, Xu G, Xia M, Xu Y, et al. Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats. PLoS One. 2014; 9(3):e83895. Epub 2014/03/22. doi:10.1371/journal.pone.0083895 PMID: 24647044.
43. Haak AJ, Tsou PS, Amin MA, Ruth JH, Campbell P, Fox DA, et al. Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury. J Pharmacol Exp Ther. 2014; 349(3):480-6. Epub 2014/04/08. doi:10.1124/jpet.114.213520 PMID: 24706986; PubMed Central PMCID: PMC4019321.
44. Li S, Chang S, Qi X, Richardson JA, Olson EN. Requirement of a myocardin-related transcription factor for development of mammary myoepithelial cells. Mol Cell Biol. 2006; 26(15):5797-808. PMID: 16847332.
45. Tumelty KE, Smith BD, Nugent MA, Layne MD. Aortic Carboxypeptidase-like Protein (ACLP) Enhances Lung Myofibroblast Differentiation through Transforming Growth Factor beta Receptor-dependent andindependent Pathways. J Biol Chem. 2014; 289(5):2526-36. Epub 2013/12/18. doi:10.1074/jbc.M113.502617 PMID: 24344132; PubMed Central PMCID: PMC3908388.
46. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988; 15(2):202-5. PMID: 3361530.
47. Nikitorowicz-Buniak J, Shiwen X, Denton CP, Abraham D, Stratton R. Abnormally Differentiating Keratinocytes in the Epidermis of Systemic Sclerosis Patients Show Enhanced Secretion of CCN2 and S100A9. J Invest Dermatol. 2014; 134(11):2693-702. doi:10.1038/jid.2014.253 PMID: 24933320.
48. Huang DP, Zhuo YH, Cai JH, Xu N, Zhong XF, Yu YY, et al. Histological and ultrastructural study on the medial canthal ligament of blepharophimosis, ptosis and epicanthus inversus syndrome. Chin Med J (Engl). 2009; 122(22):2700-4. Epub 2009/12/03. PMID: 19951599.
49. Dacic S, Kalajzic I, Visnjic D, Lichtler AC, Rowe DW. Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res. 2001; 16(7):1228-36. PMID: 11450698.
50. Sazonova OV, Lee KL, Isenberg BC, Rich CB, Nugent MA, Wong JY. Cell-cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness. Biophys J. 2011; 101(3):622-30. doi:10.1016/j.bpj.2011.06.051 PMID: 21806930; PubMed Central PMCID: PMC3145282.
51. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000; 275(20):15220-5. Epub 2000/05/16. PMID: 10809757.
52. Chen Y, Shi-Wen X, van Beek J, Kennedy L, McLeod M, Renzoni EA, et al. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am J Pathol. 2005; 167(6):1699-711. PMID: 16314481.
53. Yuan H, Kononov S, Cavalcante FS, Lutchen KR, Ingenito EP, Suki B. Effects of collagenase and elastase on the mechanical properties of lung tissue strips. J Appl Physiol. 2000; 89(1):3-14. Epub 2000/07/25. PMID: 10904029.
54. Moinzadeh P, Denton CP, Abraham D, Ong V, Hunzelmann N, Eckes B, et al. Biomarkers for skin involvement and fibrotic activity in scleroderma. Journal of the European Academy of Dermatology and Venereology: JEADV. 2012; 26(3):267-76. Epub 2011/08/09doi:10.1111/j.1468-3083.2011.04206.xPMID: 21819452.
55. Fang F, Yang Y, Yuan Z, Gao Y, Zhou J, Chen Q, et al. Myocardin-related transcription factor A mediates OxLDL-induced endothelial injury. Circ Res. 2011; 108(7):797-807. doi:10.1161/CIRCRESAHA.111.240655 PMID: 21330600.
56. Yang Y, Chen D, Yuan Z, Fang F, Cheng X, Xia J, et al. Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1. Nucleic Acids Res. 2013; 41 (12):6005-17. Epub 2013/04/30. doi:10.1093/nar/gkt311 PMID: 23625963; PubMed Central PMCID: PMC3695508.
57. Becvar R, Stork J, Pesakova V, Stanova A, Hulejova H, Rysova L, et al. Clinical correlations of potential activity markers in systemic sclerosis. Ann N Y Acad Sci. 2005; 1051:404-12. Epub 2005/08/30. doi:10.1196/annals.1361.082 PMID: 16126982.
58. Shi-wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, Black CM, et al. Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts. Arthritis Rheum. 2007; 56(12):4189-94. Epub 2007/12/01. doi:10.1002/art.23134 PMID: 18050250.
59. Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G III, Gerber ML, Jimenez SA, et al. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford). 2009; 48(7):734-40. Epub 2009/05/15. doi:10.1093/rheumatology/kep091 PMID: 19439502; PubMed Central PMCID: PMC2696027.
60. Jimenez SA. Role of Endothelial to Mesenchymal Transition in the Pathogenesis of the Vascular Alterations in Systemic Sclerosis. ISRN rheumatology. 2013; 2013:835948. Epub 2013/11/01. doi:10.1155/2013/835948PMID: 24175099; PubMed Central PMCID: PMC3794556.
61. Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, et al. Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. Arthritis Res Ther. 2010; 12(4):R128. Epub 2010/07/07. doi:10.1186/ar3066 PMID: 20602758; PubMed Central PMCID: PMC2945018.
62. Yu L, Weng X, Liang P, Dai X, Wu X, Xu H, et al. MRTF-A mediates LPS-induced pro-inflammatory transcription by interacting with the COMPASS complex. J Cell Sci. 2014. doi:10.1242/jcs.152314 PMID: 25189621.
63. Xie L. MKL1/2 and ELK4 co-regulate distinct serum response factor (SRF) transcription programs in macrophages. BMC Genomics. 2014; 15:301. Epub 2014/04/25. doi:10.1186/1471-2164-15-301 PMID: 24758171; PubMed Central PMCID: PMC4023608.
64. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma [see comments]. Arthritis Rheum. 1992; 35(1):67-72. PMID: 1731816.
65. Hinkel R, Trenkwalder T, Petersen B, Husada W, Gesenhues F, Lee S, et al. MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nature communications. 2014; 5:3970. Epub 2014/06/10. doi:10.1038/ncomms4970PMID: 24910328.
66. Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, et al. Epithelial Cells Promote Fibroblast Activation via IL-1alpha in Systemic Sclerosis. J Invest Dermatol. 2010. PMID: 20445556.
67. Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, et al. Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology (Oxford). 2008; 47(12):1754-60. PMID: 18829709. doi:10.1093/rheumatology/ken370.
68. Connelly JT, Gautrot JE, Trappmann B, Tan DW, Donati G, Huck WT, et al. Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions. Nat Cell Biol. 2010; 12(7):711-8. Epub 2010/06/29. doi:10.1038/ncb2074 PMID: 20581838.
69. Fleischmajer R, Timpl R, Tuderman L, Raisher L, Wiestner M, Perlish JS, et al. Ultrastructural identification of extension aminopropeptides of type I and III collagens in human skin. Proc Natl Acad Sci U S A. 1981; 78(12):7360-4. PMID: 7038677.
70. Gieni RS, Hendzel MJ. Mechanotransduction from the ECM to the genome: Are the pieces now in place? J Cell Biochem. 2008; 104(6):1964-87. Epub 2007/06/05. doi:10.1002/jcb.21364 PMID: 17546585.
71. Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, et al. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol. 2010; 190(4):693-706. PMID: 20733059. doi:10.1083/jcb.201004082.
72. Lagna G, Ku MM, Nguyen PH, Neuman NA, Davis BN, Hata A. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J Biol Chem. 2007; 282(51):37244-55. PMID: 17947237.
73. Liu S, Kapoor M, Leask A. Rac1 expression by fibroblasts is required for tissue repair in vivo. Am J Pathol. 2009; 174(5):1847-56. PMID: 19349358. doi:10.2353/ajpath.2009.080779.
74. Liu S, Kapoor M, Shi-wen X, Kennedy L, Denton CP, Glogauer M, et al. Role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1-knockout mice. Arthritis Rheum. 2008; 58 (7):2189-95. PMID: 18576327. doi:10.1002/art.23595.
75. Fintha A, Gasparics A, Fang L, Erdei Z, Hamar P, Mozes MM, et al. Characterization and role of SCAI during renal fibrosis and epithelial-to-mesenchymal transition. Am J Pathol. 2013; 182(2):388-400. Epub 2012/11/28. doi:10.1016/j.ajpath.2012.10.009PMID: 23178076.
76. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A. 2004; 101(20):7618-23. Epub 2004/05/07. doi:10.1073/pnas.0307512101 PMID: 15128949; PubMed Central PMCID: PMC419655.
77. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem. 2001; 276(14):10594-601. Epub 2001/01/21doi:10.1074/jbc.M010149200 PMID: 11152469.
78. Shi-Wen X, Denton CP, McWhirter A, Bou-Gharios G, Abraham DJ, du Bois RM, et al. Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis. Arthritis Rheum. 1997; 40(7):1237-44. PMID: 9214423.
79. Chen Y, Shi-wen X, Eastwood M, Black CM, Denton CP, Leask A, et al. Contribution of activin receptor- like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum. 2006; 54(4):1309-16. PMID: 16575856.
80. Shi-wen X, Parapuram SK, Pala D, Chen Y, Carter DE, Eastwood M, et al. Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts. Arthritis Rheum. 2009; 60(1):234- 41. PMID: 19116914. doi:10.1002/art.24223.
81. Velasquez LS, Sutherland LB, Liu Z, Grinnell F, Kamm KE, Schneider JW, et al. Activation of MRTF-Adependent gene expression with a small molecule promotes myofibroblast differentiation and wound healing. Proc Natl Acad Sci U S A. 2013; 110(42):16850-5. Epub 2013/10/02. doi:10.1073/pnas.1316764110 PMID: 24082095; PubMed Central PMCID: PMC3801009.
82. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Helene Sage E. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol. 2003; 120(6):949-55. Epub 2003/06/06. doi:10.1046/j.1523-1747.2003.12241.x PMID: 12787119.
83. Driskell RR, Lichtenberger BM, Hoste E, Kretzschmar K, Simons BD, Charalambous M, et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature. 2013; 504 (7479):277-81. Epub 2013/12/18doi:10.1038/nature12783 PMID: 24336287.
84. Sakai N, Chun J, Duffield JS, Wada T, Luster AD, Tager AM. LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J. 2013; 27(5):1830-46. Epub 2013/01/17. doi:10.1096/fj.12-219378 PMID: 23322166; PubMed Central PMCID: PMC3633809.
85. Ni J, Dong Z, Han W, Kondrikov D, Su Y. The role of RhoA and cytoskeleton in myofibroblast transformation in hyperoxic lung fibrosis. Free Radic Biol Med. 2013; 61C:26-39. Epub 2013/03/23. doi:10.1016/j.freeradbiomed.2013.03.012 PMID: 23517783.
86. Johnson LA, Rodansky ES, Haak AJ, Larsen SD, Neubig RR, Higgins PD. Novel Rho/MRTF/SRF Inhibitors Block Matrix-stiffness and TGF-beta-Induced Fibrogenesis in Human Colonic Myofibroblasts. Inflamm Bowel Dis. 2014; 20(1):154-65. Epub 2013/11/28. doi:10.1097/01.MIB.0000437615.98881 31 PMID: 24280883.
87. Tian W, Hao C, Fan Z, Weng X, Qin H, Wu X, et al. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells. J Hepatol. 2015; 62(1):165-74. doi:10.1016/j.jhep.2014.07.029 PMID: 25109772.
88. Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, et al. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Frontiers in pharmacology. 2014; 5:167. Epub 2014/08/08. doi:10.3389/fphar.2014.00167 PMID: 25100997; PubMed Central PMCID: PMC4105921.
89. Xu H, Wu X, Qin H, Tian W, Chen J, Sun L, et al. Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy. J Am Soc Nephrol. 2014. doi:10.1681/ASN.2014070678 PMID: 25349198.
90. Evelyn CR, Wade SM, Wang Q, Wu M, Iniguez-Lluhi JA, Merajver SD, et al. CCG-1423: A small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007; 6(8):2249-60. Epub 2007/08/19. doi:10.1158/1535-7163.MCT-06-0782 PMID: 17699722.